Coordination-driven robust antibacterial coatings using catechol-conjugated carboxymethyl chitosan

Int J Biol Macromol. 2023 Sep 30:249:126090. doi: 10.1016/j.ijbiomac.2023.126090. Epub 2023 Aug 3.

Abstract

To prevent bacterial contamination on solid surfaces, a simple yet efficient antibacterial coating was developed in a substrate-independent manner by using the catechol-conjugated carboxymethyl chitosan (CMC-DOPA). The CMC-DOPA was firstly synthesized via an aza-Michael reaction with methyl acrylate and the subsequent acyl substitution with dopamine. The coating strategy consists of spin-coating-assisted deposition of CMC-DOPA on polydopamine-coated substrates and coordination-driven crosslinks between catechol groups and Fe3+ ions in sequence, producing the multilayered CMC-DOPA films. The film thickness was controllable depending on the concentration of CMC-DOPA. Compared to bare controls, the CMC-DOPA-coated substrates reduced the bacterial adhesion by up to 99.8 % and 96.2 % for E. coli and S. aureus, respectively. It is demonstrated that the CMC-DOPA coating can be a robust antibacterial coating across various pH environments, inhibiting bacterial adhesion by 78.7 %, 95.1 %, and 93.2 %, respectively, compared to the control, even after 7 days of acidic, physiological, and alkaline pH treatment. The current coating approach could be applied to various substrates including silicon dioxide, titanium dioxide, and polyurethane. Given its simple and versatile coating capability, we think that the coordination-driven CMC-DOPA coating could be useful for various medical devices and implants.

Keywords: Antibacterial coating; CMC-DOPA; Coordination.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Chitosan*
  • Coated Materials, Biocompatible / pharmacology
  • Dihydroxyphenylalanine
  • Dopamine / pharmacology
  • Escherichia coli
  • Staphylococcus aureus

Substances

  • Chitosan
  • Anti-Bacterial Agents
  • Dopamine
  • Dihydroxyphenylalanine
  • Coated Materials, Biocompatible